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in these patients revascularization should always be
considered as a treatment option.
In the past, revascularization in such patients was
associated with increased operative mortality rates.6
Recent studies7-9 report lower mortality rates but often
use selection criteria to exclude high-risk patients or
those “least likely to benefit from revascularization.” It
has been suggested that symptoms of angina versus
symptoms of heart failure are associated with a favor-
able outcome.10 Others recommend demonstration of
reversible ischemia or viability of hibernating
myocardium by positron emission tomographic scan-
ning or dobutamine echocardiography to select patients
for this approach.11-13 In other centers revascularization
in patients with poor LV function has been recom-
mended only when distal vessels are eminently
graftable.14
P atients with coronary disease and advanced left ven-tricular (LV) dysfunction (ejection fraction [EF]
<20%) have a poor prognosis. When treated medically,
they have limited survival1-5 and usually die of cardiac
causes. Transplantation is an effective treatment option
but is limited by availability of donor organs. Therefore
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We have taken a more liberal approach to revascular-
ization in patients with poor EF (<20%). We have not
excluded patients because of lack of significant angina
or uncertainty about completeness of revascularization,
nor have we used viability studies to select candidates
for grafting. In patients with poor LV function and an
akinetic or dyskinetic area, we used intraoperative
assessment of regional wall thickness and contractility
to determine whether the area in question is viable and
should be revascularized or whether it has undergone
enough scarring and thinning to warrant resection (par-
tial ventriculectomy) and operative remodeling.15
Patients undergoing wall excision were excluded from
this series. Patients with EFs of less than 20% were
considered unsuitable for surgery if they had angio-
graphic evidence of diffuse distal disease in all vessels,
severe mitral regurgitation, or comorbidities that signif-
icantly increased operative risk.
In patients with little functional reserve, we believe
favorable results can be achieved only with optimal
myocardial protection. We have assessed delivery of
cold cardioplegic solution by temperature mapping and
used an integrated approach (antegrade ± retrograde ±
infusion through grafts) to obtain uniform cooling.
The present study was undertaken to review the
results achieved by using this approach. We review
indications for operation, operative morbidity and mor-
tality rates, improvement in symptom status, and late
survival in our series (study group). To assess the effect
of cardioplegic technique on early results, we have
compared study patients with a group of case-matched
control subjects in whom myocardial protection was
not guided by temperature mapping.
Methods
Between January 1982 and September 1997, 2359 patients
underwent isolated coronary artery bypass grafting by one
author (L. M.) at The Toronto Hospital. Of these, 125 consec-
utive patients with EFs of less than 20%, as determined by
cineangiography, comprised the study group. Data were
prospectively collected by trained chart reviewers by using a
standard data collection form. A less-detailed data set acquired
prospectively on all patients operated on at The Toronto
Hospital was used to obtain our control group. From this large
pool (470 patients), the single patient with the best match for
EF (<20%), year of operation, age, sex, symptom class, and
urgency was chosen for the control group. Because of concern
about the fairness of comparison between the study and con-
trol groups, we attempted to develop a propensity score for
membership in the study group versus the control group by
using multivariable logistic regression. Variables analyzed
included age, sex, symptom class, acute coronary insufficien-
cy, recent myocardial infarction, surgical priority, extent of
coronary artery disease, presence or absence of left main
stenosis, diabetes, hypertension, and peripheral vascular dis-
ease. The only variable found to be an independent predictor
of group membership was left main coronary artery disease,
which was more prevalent in the control group. The direction
of results in each of these subgroups was the same as that seen
in the overall matched case analysis.
Preoperative clinical variables are given in Table I. Timing
of operation was designated as elective on the same admis-
sion, urgent (within 72 hours of an event), or emergency
(from cardiac care unit or catheterization laboratory with an
acutely unstable patient). Information with regard to primary
indication for an operation or ventricular arrhythmia was
available only for the study group.
Catheterization data. Catheterization data are shown in
Table II. Cardiac catheterization was performed in all patients
to assess ventricular function and extent of coronary disease.
Coronary narrowing of 50% or greater was considered sig-
nificant. The number of diseased vessels, EF, and, in the
study group, the number of vessels with poor visualization
(questionably graftable) were recorded.
Operative technique. Fentanyl citrate was used for induc-
tion and maintenance of anesthesia. Between 1982 and 1989,
moderate systemic hypothermia (25°C) was used. Since
1989, body temperature has been allowed to drift, and no
active cooling has been used (mild hypothermia).
Cardioplegic techniques have evolved over time. Cold crys-
talloid solution switched to cold blood in 1983, and a termi-
nal hot shot was added in 1985.
In the study group after initial delivery of 1 L of cold car-
dioplegic solution, myocardial temperature in three major
distributions was measured. In cases of unsatisfactory cool-
ing (regional temperature >18°C), a graft was constructed to
the warm area first (diagonal in the case of disease of the left
anterior descending coronary artery with planned use of the
left internal thoracic artery [LITA]) and additional cardio-
plegic solution was given down the completed graft to
achieve uniform cooling. Since 1993, in cases of inadequate
cooling, retrograde cardioplegia has been used.
In the control group (Table III) a variety of cardioplegic
techniques have been used (cold, warm or tepid, antegrade,
retrograde, and down completed grafts), but temperature
mapping was not used to ensure uniform delivery.
Information obtained from operative records included tech-
nique of myocardial protection, number of grafts, use of
LITA, pump time, crossclamp time, and, in study cases,
information about the size and quality of distal vessels (Table
III).
Postoperative care and outcome. Operative mortality
(death within 30 days or during hospital stay) and morbidity
rates were reviewed. Definitions for perioperative myocardial
infarction, low-output syndrome, and perioperative stroke
have been previously reported.16 For study cases, follow-up
was performed in 1998 by telephone interview with the
patient or referring physician and office visits when clinical-
ly indicated.
Statistical analysis. The SAS (SAS Institute, Cary, NC)
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and BMDP (BMDP Software, Los Angeles, Calif) programs
were used for statistical analyses. 
Patient characteristics and hospital outcomes were compared
by using t tests for continuous variables and the χ2 or Fisher
exact test for categoric variables. Differences between preop-
erative and postoperative symptom status were compared by
using linear trend analysis. Results are presented as means ±
SD in the text and tables and means ± SEM in the figures.
The late survival was evaluated univariately by using
Kaplan-Meier analyses and multivariately by using the Cox
proportional hazards model with the following building strat-
egy: variables with a univariate P value of less than .25 or
those of known biologic importance but failing to meet the
critical α-level were submitted for consideration to the mul-
tivariate analysis by means of stepwise selection. Variables
considered for analysis in predicting long-term survival
included age, sex, symptom class, presence or absence of
congestive heart failure, severity of angina, urgency of
surgery, recent myocardial infarction, diabetes, hypertension,
peripheral vascular disease, preoperative intra-aortic balloon
pumping, perioperative ventricular arrhythmias, primary
indication for surgery, number of diseased vessels, left main
stenosis, poorly visualized distal vessels, mitral regurgitation,
and use of the LITA. Variables actually included in the Cox
analysis were age, sex, symptoms at rest, congestive heart
failure, mitral regurgitation, number of diseased vessels, and
poorly visualized vessels. Statistical significance of differ-
ences in the Kaplan-Meier survival curves were determined
by using the log-rank test.
Population characteristics. Population characteristics are
shown in Table I. There were 125 patients in both the study
and control groups (112 men and 13 women). Average age
was 60 ± 10 years. The groups were comparable with respect
to comorbid factors (including diabetes, hypertension, and
peripheral vascular disease), severity of angina, need for pre-
operative intra-aortic balloon pump support, and extent of
coronary artery disease (Table II).
Table I. Preoperative clinical variables
Control 
Study group subjects P value
Age (y) 60 ± 10 60 ± 10 >.2
Sex (M/F) 112/13 112/13 >.2
Overall symptom class
I 3/125 (2%) 2/125 (2%) >.2
II 14/125 (11%) 13/125 (10%)
III 39/125 (31%) 42/125 (34%)
IV 69/125 (55%) 68/125 (54%)
CHF* 31/97 (32%) 21/97 (22%) .11
Severity of angina
0 - none 0 0 >.2
I - stable 47/125 (38%) 46/125 (37%)
II - crescendo 49/125 (39%) 46/125 (37%)
III - acute coronary 29/125 (23%) 33/125 (26%)
insufficiency
Timing
Elective 79/125 (63%) 83/125 (66%) >.2
Same hospitalization 16/125 (13%) 22/125 (18%)
Urgent 26/125 (21%) 16/125 (13%)
Emergency 4/125 (3%) 4/125 (3%)
Diabetes 24/83 (29%) 21/81 (26%) >.2
Hypertension 57/97 (59%) 30/69 (44%) .05
PVD 19/97 (20%) 16/85 (19%) >.2
Preoperative IABP 7/125 (6%) 5/125 (4%) >.2
Preoperative ventricular 
arrhythmia
PVCs 8/125 (6%)
VT/VF 31/125 (25%)
Primary indication for 
operation
Heart failure 9/125 (7%)
Angina 62/125 (50%)
Both 36/125 (29%)
Ventricular arrhythmia 2/125 (2%)
Critical anatomy 16/125 (13%)
PVD, Peripheral vascular disease; IABP, intra-aortic balloon pump; PVC, pre-
mature ventricular contraction. 
*Information unavailable from divisional database before 1990.
Table II. Catheterization data
Control 
Study group subjects P value
Diseased vessels
1 2/125 (2%) 4/125 (3%) >.2
2 24/125 (18%) 23/125 (18%)
3 100/125 (80%) 100/125 (80%)
Left main 14/125 (11%) 17/125 (14%)
Possibly nongraftable 
vessels
LAD 25/125 (20%)
Right 41/125 (33%)
Circumflex 16/125 (13%)
MR ≥2+ 48/125 (38%)
Average EF (%) 18 ± 5
LAD, Left anterior descending; MR, mitral regurgitation.
Table III. Intraoperative variables
Control 
Study group subjects P value
Average No. of grafts 3.7 ± 0.7 3.5 ± 1.0 >.2
Pump time (min) 117.4 ± 30.7 85.7 ± 23.2 .0001
Crossclamp time (min) 69.5 ± 17.9 59.7 ± 18.7 .0004
Use of LITA 91/125 (73%) 70/125 (56%) .005
Myocardial protection
Mild hypothermia 58/125 (46%) 62/125 (50%)
Moderate hypothermia 67/125 (54%) 63/125 (50%) >.2
Type of cardioplegia
Cold crystalloid 6/125 (5%) 5/125 (4%)
Cold blood 119/125 (95%) 109/125 (87%)
Tepid blood 0 7/125 (6%)
Warm blood 0 4/125 (3%) .009
Mode of delivery
Antegrade 112/125 (90%) 107/125 (86%)
Retrograde ± antegrade 13/125 (10%) 18/125 (14%) >.2
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In the study group the primary indication for the operation
was angina in 50%, heart failure in 7%, angina and heart fail-
ure in 29%, and ventricular arrhythmia in 2%. In the remain-
ing patients with critical anatomy, an operation was recom-
mended to improve prognosis. Preoperative ventricular
arrhythmia was documented in 31% of patients, 54% had at
least 1 poorly visualized vessel, and 38% had mild-to-moder-
ate mitral regurgitation (2 to 3+).
The groups were comparable with respect to the degree of
systemic hypothermia, the proportion receiving crystalloid or
blood cardioplegia, and the proportion receiving antegrade or
retrograde (with or without antegrade) cardioplegia. Only 11
patients in the control group received anything other than
cold cardioplegia.
Table III lists intraoperative variables. The crossclamp and
pump times were longer in the study group. Seventy-five per-
cent of study patients had a LITA graft versus 56% in the con-
trol group (P = .005).
Results
The operative mortality rate was 4% in study patients
versus 11% in control subjects (P = .03, Table IV).
Low-output syndrome occurred in 19% of study
patients and 30% of control subjects (P = .06). Intra-
aortic balloon pump support was required in 15% of
study group patients versus 30% of control subjects (P
= .004). The prevalence of perioperative complications,
including myocardial infarction, stroke, reoperation for
bleeding, and sternal infection, was similar in the two
groups.
As determined by using univariate analysis, the hos-
pital mortality rate was not related to the technique of
cardioplegia: antegrade versus retrograde (with or
without antegrade) cardioplegia 17 (8.4%) of 202 ver-
sus 2 (6.5%) of 31 (P > .2) or the degree of hypother-
mia (mild vs moderate) 8 (6.7%) of 120 versus 11
(9.2%) of 130 (P > .2). The hospital mortality rate was,
however, significantly lower in patients in whom car-
dioplegia was guided by temperature mapping (5 [4%]
of 125 vs 14 [11.2%] of 125, P = .03).
With respect to hospital deaths in the study group, 1
patient receiving long-term amiodarone died of acute
respiratory distress syndrome, 1 with a preoperative
intra-aortic balloon pump for cardiogenic shock died of
congestive heart failure, 1 died of low-output syn-
drome, and 2 died of ventricular arrhythmias. In this
group antiarrhythmic medication (not including β-
blockers) was required briefly (<24 hours) to suppress
premature ventricular contractions in 18 (14%) of 125
patients. Prolonged antiarrhythmic therapy was used in
an additional 41 (33%) patients (19 for premature ven-
tricular contractions, 14 for ventricular tachycardia/
ventricular fibrillation [VT/VF], and in 8 patients drugs
were given prophylactically because of a history of
VT/VF). Twenty-seven (22%) patients were discharged
with antiarrhythmic medications.
In the control group hospital deaths were related to
congestive heart failure or low-output syndrome in 8
and ventricular arrhythmia in 2 patients. One patient
died of a pulmonary embolus. In 3 patients the cause of
death could not be determined (charts destroyed).
Follow-up in study patients extends from 6 months to
15 years (mean, 48 ± 39 months). There have been 33
late deaths (4 sudden deaths, 17 nonsudden cardiac
deaths, 4 noncardiac deaths, and 8 deaths of unknown
cause). At 5 years, actuarial survival is 72%, and free-
dom from sudden death is 94% (Fig 1).
By using univariate analysis, 4 preoperative variables
adversely affected long-term survival—advanced age,
overall class IV symptoms, heart failure class IV symp-
toms, and poorly visualized distal vessels. A LITA graft
favorably affected long-term survival. According to mul-
tivariate Cox regression analysis, age, overall class IV
symptoms, and poorly visualized vessels predicted
decreased long-term survival. Other preoperative vari-
ables, such as the presence or absence of significant angi-
Table IV. Results
Study group Control subjects P value
Hospital mortality 5/125 (4%) 14/125 (11%) .03
Low-output syndrome 24/125 (19%) 37/125 (30%) .06
Perioperative myocardial 5/125 (4%) 9/125 (7%) >.2
infarction
Postoperative IABP 19/125 (15%) 38/125 (30%) .004
Stroke 5/125 (4%) 4/125 (3%) >.2
Reoperation for bleeding 1/125 (1%) 2/125 (2%) >.2
Sternal wound infection 3/125 (2%) 4/125 (3%) >.2
IABP, Intra-aortic balloon pump.
Fig 1. Study group: actuarial survival and freedom from sud-
den death at 1, 2, and 5 years.
554 Mickleborough et al The Journal of Thoracic and
Cardiovascular Surgery
March 2000
na, ventricular arrhythmia, or significant mitral regurgita-
tion (2 to 3+), had no effect on long-term survival (Fig 2).
Fig 3 compares preoperative and postoperative symp-
tom status for angina and heart failure among survivors
in the study group. Mean anginal class improved from
3.2 ± 1.0 preoperatively to 1.3 ± 0.7 postoperatively,
and 66 (74%) of 89 were improved by at least one
Canadian Cardiovascular Society class (P = .07 by lin-
ear trend analysis). The mean congestive heart failure
class improved from 2.2 ± 1.2 preoperatively to 1.4 ±
0.7 postoperatively, and 36 (40%) of 89 were improved
by at least one New York Heart Association class (P =
.04 by linear trend analysis).
During follow-up, 34 (39%) of 88 of survivors have
required rehospitalization, 20 for cardiac reasons (15
for congestive heart failure, including 2 myocardial
infarctions, and 5 for arrhythmias, including 2 with
atrial fibrillation). No patient has been referred for
transplantation, mitral valve replacement, or insertion
of an automatic implantable cardioverter defibrillator.
A permanent pacemaker was implanted in 2 patients
for bradyarrhythmia.
Fig 2. Actuarial survival for patient subgroups with and without significant angina (Canadian Cardiovascular
Society [CCS] class III and IV vs I and II), class IV heart failure symptoms, significant mitral regurgitation, pre-
operative ventricular arrhythmia, overall class IV symptoms, and poorly visualized distal vessels. Asterisks (*)
indicate a statistically significant difference between curves as determined by using the log-rank test (P < .05).
NYHA, New York Heart Association; MR, mitral regurgitation.
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Discussion
Medical treatment of patients with coronary disease
and poor LV function is associated with poor results.
Louie and colleagues4 reported a less than 25% 3-year
survival in 54 patients (mean EF, 22%), and Luciani
and colleagues5 reported a 28% 5-year survival in 72
patients (mean EF, 21%).
Cardiac transplantation is very effective, but the num-
ber of transplants is limited by donor availability.17
Only 10% of eligible patients actually undergo trans-
plantation, and many die on the waiting list.18
Results of this study support the use of bypass graft-
ing in patients with low EF (<20%). Our hospital mor-
tality rate of 4% and 1- and 5-year survival of 90% and
72% compare favorably with those from recent series
in which hospital mortality rates ranged from 2.6% to
13% and 5-year survival ranged from 50% to
73%.7,10,19,20 Clearly, case selection, as well as anes-
thetic and cardioplegic techniques, may account for
these differences.
Case selection. Recent studies have suggested that
increased LV size is a risk factor for perioperative mor-
tality in patients with low EF undergoing bypass
surgery.21 With poor ventricular function and chamber
dilatation, it is often impossible, on the basis of preop-
erative ventriculography, to determine what areas of the
heart may benefit from revascularization (hibernating
myocardium) and what areas have undergone signifi-
cant scarring and thinning, in which case partial ven-
triculectomy and surgical reconstruction may be of
benefit.5,15 Some centers recommend preoperative via-
bility studies to select patients for revascularization.9,11,13
Patients without evidence of flow-metabolism mismatch
and without an area of obvious dyskinesis may be con-
sidered poor candidates for surgery.
We believe that all patients with graftable coronary
disease, poor LV function, and akinetic or dyskinetic
regions of the ventricle will benefit from surgery. We
recommend intraoperative assessment of regional wall
thickness and contractility to guide the operative proce-
dure. If the area in question is scarred, thinned, and
nonfunctioning, we proceed with excision to decrease
LV volume and wall stress. During the time frame of
this study, 53 patients with an EF of less than 20% have
undergone partial ventriculectomy or aneurysm resec-
tion. Our results with this approach have been previ-
ously reported.15 If the akinetic or dyskinetic area cor-
responds to a thick region of myocardium mixed with
scar or if contractility is observed in the unloaded state
(on bypass), then revascularization is carried out. Either
way, surgery has something to offer. Our operative
mortality rate of 4% and 5-year survival of 72% com-
pare favorably with results recently reported by DiCarli
and colleagues in patients (EF < 40%) who had flow-
metabolism mismatch on positron emission tomo-
graphic scanning: operative mortality rate of 11%11 and
5-year survival of 75%.12
Langenburg and colleagues14 have recommended that
patients with poor LV function and poor visualization of
distal vessels are not good candidates for revasculariza-
tion. Our study group included 67 patients with at least
one poorly visualized vessel. Poor visualization on the
preoperative angiogram does not necessarily correlate
with poor quality of distal vessels or incomplete revas-
cularization at surgery. For example, in patients with a
poorly visualized left anterior descending artery, 24 of
25 were successfully grafted. In 16 patients with a poor-
ly visualized circumflex, 14 were grafted, with 1
A
B
Fig 3. Preoperative (preop) and postoperative (postop) symp-
tom status for angina (Canadian Cardiovascular Society
[CCS]) and congestive heart failure (New York Heart Associ-
ation [NYHA]) in survivors showing percentage of patients in
each group.
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endarterectomy. In 41 patients with poor visualization
of the right coronary artery, 38 were grafted, but 13
endarterectomies were required. Therefore, of 67
patients with poorly visualized vessels, complete revas-
cularization was achieved in all but 6.
Four of 5 hospital deaths occurred in patients with
poorly visualized vessels (1 with incomplete revascular-
ization), and the long-term survival rate in this group
was significantly lower than that found in patients with
well-visualized vessels (Fig 2). Nevertheless, 67% of
patients with poorly visualized vessels were alive at 5
years. For this reason, we will continue to include such
patients in our series. We consider inoperable only those
with EFs of less than 20% and poor visualization or evi-
dence of diffuse disease in all three vessel distributions.
Cardioplegic techniques. We agree with Kaul and
colleagues20 that myocardial protection is extremely
important in patients with poor LV function. Any single
approach to delivery of cardioplegic solution may
result in inadequate protection (antegrade delivery
because of coronary stenosis or undetected aortic insuf-
ficiency and retrograde delivery because of inadequate
flow to the right coronary bed or imperfect coronary
sinus catheter position). With cold cardioplegia, tem-
perature mapping can be used to assess delivery, and
additional doses can be given retrograde or down ini-
tially completed grafts to ensure rapid uniform cool-
ing.22,23 We used this technique in our study group.
In control subjects various cardioplegic techniques
were used, including tepid or warm cardioplegia in a
small subset of 11 patients. In control subjects temper-
ature mapping was not used to ensure uniform cardio-
plegia delivery.
Improved results in the study group. We attempted
to determine what factors were responsible for the
lower hospital morbidity and mortality rates observed
in the study group (mortality 4% vs 11%, P = .03;
intra-aortic balloon pump support 15% vs 30%, P =
.004). Unfortunately, the number of hospital deaths in
this series is too small to allow meaningful multivariate
analysis. By study design, control patients were
matched for factors expected to affect morbidity and
mortality rates, including LV function, age, sex, overall
symptom class, and urgency of surgery.24 The two
groups were also comparable with respect to comor-
bidities, extent of coronary disease, and number of
grafts performed. Crossclamp time and pump time
were longer in study patients in keeping with time
needed for temperature mapping and additional cardio-
plegia delivery.
More study patients received an internal thoracic
artery (ITA) graft; however, the hospital mortality rate
was not different in patients receiving a LITA (10/161
[6.3%]) versus those without (9/90 [10%], P > .2).
Although it is possible that increased use of the ITA
may have contributed to improved results in study
patients, we believe that the decreased hospital mor-
bidity and mortality rates in this group were likely
caused by improved myocardial protection afforded by
temperature mapping.
Ventricular arrhythmia. In previous reports of
patients with low EF undergoing revascularization,
ventricular arrhythmia has been a common cause of
hospital and late death.7,10 Kaul and colleagues20
reported that long-term survival was decreased in
patients with a history of VT/VF. His group did not per-
form preoperative electrophysiologic studies and used
drug therapy or automatic implantable cardioverter
defibrillators to control postoperative arrhythmia.
We have had a special interest in the surgical treat-
ment of ventricular arrhythmia, and 25% of our study
group had a history of VT/VF. In our center patients
with coronary disease and spontaneous VT/VF have
preoperative electrophysiologic testing. If VT is
inducible, they are considered for directed surgical VT
ablation and excluded from this series.25 Our study
group included 10 patients turned down for VT surgery
because of age greater than 65 years, noninducible VT,
or lack of a transmural scar to allow access for endo-
cardial ablation. All but one of these patients survived
the operation and were discharged with antiarrhythmic
drugs. In study patients postoperative ventricular
arrhythmias were treated with amiodarone as the drug
of choice. This aggressive approach (surgical VT abla-
tion when possible or treatment with amiodarone) may
explain our results with only 2 hospital deaths caused
by arrhythmias (1.6%) and only 4 late sudden deaths in
this series.
Control of symptoms and long-term survival. We
and others11,19 have demonstrated that improvement in
both anginal and heart failure status can be achieved
with revascularization in patients with poor ventricular
function. In our series, by multivariate analysis, the
only predictors of decreased long-term survival were
advanced age, overall symptom class IV, and poorly
visualized vessels. Other factors identified in previous
series as predicting poor outcome, including female
sex, hypertension, absence of significant angina, ven-
tricular arrhythmia, or moderate mitral regurgitation,
were not related to poor outcome in this series.10,24
Our results support the use of coronary artery bypass
grafting in patients with poor ventricular function (EF <
20%) and no area suitable for partial ventriculectomy or
surgical remodeling. We have shown that good results
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can be achieved without case selection on the basis of
viability studies or visibility of distal vessels. We rec-
ommend use of temperature mapping to ensure uniform
cardioplegia delivery, which may result in decreased
operative morbidity and mortality rates. The procedure
provides good relief of symptoms in most patients. In
our experience the long-term survival was encouraging
and was not significantly different in subgroups with or
without severe angina, mild-to-moderate mitral regurgi-
tation, or a preoperative history of ventricular arrhyth-
mia. Older patients, those having class IV symptoms,
and those with poorly visualized vessels had a poorer
long-term prognosis. Although postoperative ventricular
arrhythmias were frequent in this group, there were only
2 hospital deaths caused by arrhythmia, only 22% of
patients were discharged with antiarrhythmic drugs, and
freedom from sudden death was 94% at 5 years.
Revascularization should be considered as a treatment
option whenever possible in patients with coronary
artery disease and poor LV function.
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